Table 2.
Symbol | Entrez Gene Name | GenPept/ UniProt/Swiss-Prot Accession |
Expr Fold Change OP:HC | Location | Family | Bone Involvement |
---|---|---|---|---|---|---|
COL1A1 | Collagen type I alpha 1 chain | P02452 | −2.26587705 | Extracellular Space | Other | Bone matrix/Osteoblast |
COL3A1 | Collagen type III alpha 1 chain | P02461 | −6.1868361 | Extracellular Space | Other | Bone matrix/Osteoblast |
FERMT2 | Fermitin family member 2 | Q96AC1 | −6.11159085 | Cytoplasm | Other | Bone homeostasis regulation |
GLB1 | Galactosidase beta 1 | P16278 | 2.92715725 | Cytoplasm | Enzyme | |
GNAI3 | G protein subunit alpha i3 | P08754 | −2.52033996 | Cytoplasm | Enzyme | Impaired activation of integrin and ERK1/2. |
HADH | Hydroxyacyl-CoA dehydrogenase | Q16836 | 2.1108754 | Cytoplasm | Enzyme | In OP gene panel |
ITGA5 | Integrin subunit alpha 5 | P08648 | 2.88383695 | Plasma Membrane | Transmembrane Receptor | osteoclastogenesis |
KDM3A | Lysine demethylase 3A | Q9Y4C1 | 3.43441641 | Nucleus | Transcription regulator | OP associated |
MAPK3 | Mitogen-activated protein kinase 3 | P27361 | 25.6856293 | Cytoplasm | Kinase | Bone Diseases |
PCBP2 | Poly(rC) binding protein 2 | Q15366 | 2.05142965 | Nucleus | Other | |
PCOLCE | Procollagen C-endopeptidase enhancer | Q15113 | 3.37138722 | Extracellular Space | Other | osteoclast–osteoblast bone modeling |
PLOD2 | Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 | O00469 | 2.26356027 | Cytoplasm | Enzyme | bone mass syndromes |
PTPN12 | Protein tyrosine phosphatase non-receptor type 12 | Q05209 | 2.40278726 | Cytoplasm | Phosphatase | Bone resorbing |
S100A4 | S100 calcium binding protein A4 | P26447 | 2.45896457 | Cytoplasm | Other | Bone resorption osteoclast function |
YBX1 | Y-box binding protein 1 | P67809 | 2.57704761 | Nucleus | Transcription regulator |
The fold change was calculated based on the expression values of OP/HC. Therefore, the positive fold-change values mean upregulation in OP compared with HC and vice versa for negative values, i.e., upregulated in HC compared with OP.